Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice

Arthritis and Rheumatism

Volumn 62, Issue 10, 2010, Pages 2984-2994

  Boldizsar, Ferenc ^a,b   Kis Toth, Katalin ^a,c   Tarjanyi, Oktavia ^a,b   Olasz, Katalin ^a,b   Hegyi, Akos ^a   Mikecz, Katalin ^a   Glant, Tibor T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; PEPTIDE; PROTEOGLYCAN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; ARTICLE; BONE EROSION; CD4+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; EPITOPES, T-LYMPHOCYTE; INTERLEUKIN-4; LONGITUDINAL STUDIES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PEPTIDES; PROTEOGLYCANS; RECEPTORS, ANTIGEN, T-CELL;

EID: 77957684725     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27614     Document Type: Article

References (49)

1. Campbell IK, Kinkel SA, Drake SF, van Nieuwenhuijze A, Hubert FX, Tarlinton DM, et al. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 2009;60:1683-93.
2. Trentham DE, Dynesius RA, Rocklin RE, David JR. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med 1978;299:327-32.
3. Glant T, Csongor J, Szucs T. Immunopathologic role of proteoglycan antigens in rheumatoid joint diseases. Scand J Immunol 1980;11:247-52.
4. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;282:666-8.
5. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
6. Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998;160:3812-9.
7. Szanto S, Bardos T, Szabo Z, David CS, Buzas EI, Mikecz K, et al. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. Arthritis Rheum 2004;50:1984-95.
8. Buzas E, Vegvari A, Murad YM, Finnegan A, Mikecz K, Glant TT. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. Cell Immunol 2005;235: 98-108.
9. Guerassimov A, Zhang YP, Banerjee S, Cartman A, Leroux JY, Rosenberg LC, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-25.
10. De Jong H, Berlo SE, Hombrink P, Otten HG, van Eden W, Lafeber FP, et al. Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T cell responses in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2009;69:255-62.
11. Von Delwig A, Locke J, Robinson JH, Ng WF. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010;62:143-9.
12. Buzas EI, Hanyecz A, Murad Y, Hudecz F, Rajnavolgyi E, Mikecz K, et al. Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and non-arthritogenic) autoreactive T cell hybridoma clones. J Immunol 2003; 171:3025-33.
13. Berlo SE, van Kooten PJ, ten Brink CB, Hauet-Broere F, Oosterwegel MA, Glant TT, et al. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation. J Autoimmun 2005;25:172-80.
14. Berlo SE, Guichelaar T, ten Brink CB, van Kooten PJ, Hauet- Broeren F, Ludanyi K, et al. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum 2006;54:2423-33.
15. Cope AP. T cells in rheumatoid arthritis. Arthritis Res Ther 2008;10 Suppl 1:S1.
16. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306-18.
17. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-60.
18. She J, Matsui K, Terhorst C, Ju ST. Activation-induced apoptosis of mature T cells is dependent upon the level of surface TCR but not on the presence of the CD3ζ ITAM. Int Immunol 1998;10: 1733-40.
19. Metz DP, Farber DL, Taylor T, Bottomly K. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation. J Immunol 1998;161:5855-61.
20. Zhang J, Bardos T, Li D, Gal I, Vermes C, Xu J, et al. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J Immunol 2002;169:2236-40.
21. + T lymphocytes. J Immunol 2008;180:7958-68.
22. Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P. Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 2002;14:354-9.
23. Gatzka M, Walsh CM. Apoptotic signal transduction and T cell tolerance. Autoimmunity 2007;40:442-52.
24. Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002;169: 3345-52.
25. Zhang J, Bardos T, Shao Q, Tschopp J, Mikecz K, Glant TT, et al. IL-4 potentiates activated T cell apoptosis via an IL-2-dependent mechanism. J Immunol 2003;170:3495-503.
26. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-22.
27. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-61.
28. Mangialaio S, Ji H, Korganow AS, Kouskoff V, Benoist C, Mathis D. The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis. Arthritis Rheum 1999;42:2517-23.
29. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.
30. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003;100:5986-90.
31. Brennan FR, Negroiu G, Buzas EI, Fulop C, Mikecz K, Glant TT. Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin Exp Immunol 1995;100:104-10.
32. Krutzik PO, Hale MB, Nolan GP. Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol 2005;175:2366-73.
33. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
34. Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT. Th1/ Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol 2009;21:511-22.
35. Bardos T, Zhang J, Mikecz K, David CS, Glant TT. Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum 2002;46:2465-75.
36. Hanyecz A, Berlo SE, Szanto S, Broeren CP, Mikecz K, Glant TT. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum 2004;50:1665-76.
37. Tarjanyi O, Boldizsar F, Nemeth P, Mikecz K, Glant TT. Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis. Immun Ageing 2009;6:8.
38. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, et al. IFN-γ regulates the requirement for IL-17 in proteoglycan- induced arthritis. J Immunol 2010;184:1552-9.
39. Van Leeuwen JE, Samelson LE. T cell antigen-receptor signal transduction. Curr Opin Immunol 1999;11:242-8.
40. Osman GE, Cheunsuk S, Allen SE, Chi E, Liggitt HD, Hood LE, et al. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice. Int Immunol 1998;10: 1613-22.
41. Stastny P, Ball E, Kahn M, Olsen N, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 1988;27:132-8.
42. Zhang J, Bardos T, Mikecz K, Finnegan A, Glant TT. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune arthritis. J Immunol 2001;166:4981-6.
43. Van den Brink MR, Kapeller R, Pratt JC, Chang JH, Burakoff SJ. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 1999;274: 11178-85.
44. Zhong L, Wu CH, Lee WH, Liu CP. ζ-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways. J Immunol 2004;172:1472-82.
45. Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck WJ, et al. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-γ1 and Ras activation. EMBO J 1999;18:1832-44.
46. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, Perlmutter RM, et al. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci U S A 1999;96:1024-9.
47. Wang J, Hargrove ME, Ting CC. IL-2 and IL-4 mediate through two distinct kinase pathways for the activation of αCD3-induced activated killer cells. Cell Immunol 1996;174:138-46.
48. Singh K, Deshpande P, Pryshchep S, Colmegna I, Liarski V, Weyand CM, et al. ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol 2009;183:8258-67.
49. Stefanova I, Hemmer B, Vergelli M, Martin R, Biddison WE, Germain RN. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat Immunol 2003;4:248-54.